“Deucravacitinib in Moderate Plaque Psoriasis: Efficacy in the Phase 3 POETYK PSO-1 and PSO-2 Trials ” (2024) SKIN The Journal of Cutaneous Medicine, 8(2), p. s364. doi:10.25251/skin.8.supp.364.